跳至主要内容
临床试验/NCT04283292
NCT04283292已完成4 期

Capsaicin for the Treatment of Cannabinoid Hyperemesis Syndrome

University of Virginia1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2020年12月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
20
试验地点
1
主要终点
Time to resolution of symptoms

研究概览

简要总结

This study aims to determine if capsaicin cream offers symptomatic relief to patients suffering from Cannabinoid Hyperemesis Syndrome (condition that leads to repeated and severe bouts of vomiting).

详细描述

Objectives:

The purpose of this study is to determine if capsaicin cream offers symptomatic relief to patients suffering from Cannabinoid Hyperemesis Syndrome. We hypothesize that the use of topical capsaicin may provide effective symptomatic relief more quickly than conventional anti-emetic therapy alone thereby decreasing costs for continued drug therapies, repeat laboratory testing, radiographic imaging, and specialist consults.

Primary endpoint:

Time to resolution of symptoms, clinical improvement in pain score as defined by visual analog score.

Approach and methods:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Care Provider, Investigator)

盲法说明

investigational pharmacists and designated personell will the only unblinded study staff.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • At least 18 years old
  • Diagnosis of cannabinoid hyperemesis syndrome

排除标准

  • Patients who receive more than 2 anti-emetic therapies prior to screening for enrollment
  • Patients who receive haloperidol as an anti-emetic therapy
  • Pregnant women
  • Prisoners

研究组 & 干预措施

Capsaicin

Experimental

capsaicin 0.075% cream applied once topically

干预措施: Capsaicin (Drug)

Placebo

Active Comparator

placebo cream applied once topically

干预措施: Placebo (Drug)

结局指标

主要结局

Time to resolution of symptoms

时间窗: 1 day (During emergency department admission)

Time that it takes for symptoms to be resolved for those with Cannabinoid Hyperemesis Syndrome

次要结局

  • Clinical improvement in pain score(1 day (During emergency department admission))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Angela Holian

Emergency Medicine Clinical Pharmacist

University of Virginia

研究点 (1)

Loading locations...

相似试验